Keyu Sun

Dr. Keyu Sun


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in International Immunopharmacology
Verified
Journal Article
Closed access
JWJiqin Wang
Jiqin Wang
JSJianfeng Song
Jianfeng Song
YLYanyan Li
Yanyan Li
JSJinyan Shao
Jinyan Shao
ZXZichen Xie
Zichen Xie
KSKeyu Sun
Keyu Sun

7 February 2020 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
YLYang Li
Yang Li
JSJianfeng Song
Jianfeng Song
ZXZichen Xie
Zichen Xie
MLMei Liu
Mei Liu
KSKeyu Sun
Keyu Sun

1 August 2021 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
YLYongliang Li
Yongliang Li
MTMi Tian
Mi Tian
DZDongqing Zhang
Dongqing Zhang
YZYifei Zhuang
Yifei Zhuang
ZLZhimin Li
Zhimin Li
KSKeyu Sun
Keyu Sun
Background: Long non-coding RNAs (lncRNAs) have been reported to play critical roles in human tumours, including gallbladder carcinoma (GBC). However, their biological functions and molecular mechanisms in tumorigenesis and progression remain largely unknown. Methods: Quantitative polymerase chain reaction (qPCR) was used to verify the expression of lncRNA myosin light chain kinase antisense RNA 1 (MYLK-AS1) in 120 pairs of GBC tissues and paired adjacent non-tumour tissues, as well as in six different GBC cell lines (NOZ, EH-GB1, OCUG-1, GBC-SD, SGC-996 and QBC-939). Cell counting kit 8 was applied to explore cell proliferation and drug sensitivity assays. The target miRNAs (miR) of MYLK-AS1 and downstream target genes were predicted using Starbase 3.0 software and confirmed by double luciferase reporting test. The expression of proteins was assessed using Western blot assay. Results: Here, we demonstrated that MYLK-AS1 was significantly upregulated and correlated with a poor prognosis and poor clinical characteristics in GBC. Furthermore, the forced expression of MYLK-AS1 significantly promoted GBC cell proliferation and resistance to gemcitabine in vitro. Mechanistically, MYLK-AS1 functioned as an efficient miR-217 sponge, thereby releasing the inhibition of enhancer of zeste 2 polycomb repressive complex 2 (EZH2) subunit expression. MYLK-AS1 promoted GBC cell proliferation and resistance to gemcitabine by upregulating EZH2 expression, and EZH2 was confirmed as a direct target of miR-217. Discussion: Our results confirmed that the chemoresistant driver MYLK-AS1 might be a promising candidate as a therapeutic target for the treatment of advanced GBC.

1 September 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JWJiqin Wang
Jiqin Wang
MLMei Liu
Mei Liu
NDNianchang Ding
Nianchang Ding
YLYang Li
Yang Li
JSJinyan Shao
Jinyan Shao
KSKeyu Sun
Keyu Sun

12 April 2019 in The Kaohsiung Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
YLYanyan Li
Yanyan Li
CLChun‐Yan Liu
Chun‐Yan Liu
MLMei Liu
Mei Liu
KSKeyu Sun
Keyu Sun
Limb ischemia reperfusion (LIR) can activate endogenous cytoprotective mechanisms by generating specific proteins against reperfusion injury in remote organs. The present study investigated the roles of heme oxygenase‐1 (HO‐1) pathway and the molecular mechanisms underlying the regulation of this pathway on lung injury following LIR. LIR was induced by ischemia for 4 hours followed by reperfusion for 6 hours (LIR 6 hours) or 16 hours (LIR 16 hours) in male Sprague‐Dawley rats. HO‐1 inducer cobalt protoporphyrin (Copp) or HO‐1 inhibitor zinc protoporphyrin (Znpp) was intravenously injected 24 hours before ischemia. The animals were randomly divided into nine groups, including normal control, LIR 6 hours, LIR 16 hours, Copp, Copp + LIR 6 hours, Copp + LIR 16 hours, and Znpp, Znpp+ LIR 6 hours, and Znpp + LIR 16 hours groups (each group included four samples). Lung injury was examined through histopathology. Quantitative real‐time PCR, immunohistochemistry and Western blot were applied to detect the mRNA and protein levels of HO‐1, Nrf2, and Bach1. Our study showed that LIR induced Nrf2 upregulation but Bach1 downregulation to promote HO‐1 expression in lung tissues. Activation of HO‐1 pathway by Copp potentially enhanced Nrf2 expression but inhibition of the pathway by Znpp promoted Bach1 expression. Inducer of HO‐1 pathway, Copp injection improved the lung injury. Nevertheless, Znpp injection aggravated the lung injury following LIR. Our findings suggested that activated HO‐1 pathway might exert protective effects on the lung injury following LIR.

26 August 2021 in Computational and Mathematical Methods in Medicine
Verified
Journal Article
Open access
PDF file
YLYanyan Li
Yanyan Li
JWJiqin Wang
Jiqin Wang
YLYuzhen Li
Yuzhen Li
CLChunyan Liu
Chunyan Liu
XGXia Gong
Xia Gong
KSKeyu Sun
Keyu Sun
Background. Immunosuppression has a key function in sepsis pathogenesis, so it is of great significance to find immune-related markers for the treatment of sepsis. Methods. Datasets of community-acquired pneumonia (CAP) with sepsis from the ArrayExpress database were extracted. Differentially expressed genes (DEGs) between the CAP group and normal group by Limma package were performed. After calculation of immune score through the ESTIMATE algorithm, the DEGs were selected between the high immune score group and the low immune score group. Enrichment analysis of the intersected DEGs was conducted. Further, the protein-protein interaction (PPI) of the intersected DEGs was drawn by Metascape tools. Related publications of the key DEGs were searched in NCBI PubMed through Biopython models, and RT-qPCR was used to verify the expression of key genes. Results. 360 intersected DEGs (157 upregulated and 203 downregulated) were obtained between the two groups. Meanwhile, the intersected DEGs were enriched in 157 immune-related terms. The PPI of the DEGs was performed, and 8 models were obtained. In sepsis-related research, eight genes were obtained with , included in the models. Conclusion. CXCR3, CCR7, HLA-DMA, and GPR18 might participate in the mechanism of CAP with sepsis.